Mounjaro (tirzepatide injection) is approved for diabetes and weight control in adults with obesity (BMI 30+) or overweight (BMI 27+) with related health problems like high BP, cholesterol, diabetes, sleep apnoea, or heart disease 17
Some clinical studies have found that men using semaglutide, especially for weight loss rather than diabetes, might have a higher chance of developing ED
This may include additions such as glutathione, vitamin C, and zinc which help detoxify your body and improve your natural defenses
The simplicity of a single weekly injection that addresses multiple risk factors simultaneously may improve long-term adherence compared to complex multi-drug regimens
The discontinuation rate due to adverse events remained remarkably low throughout
Key takeaways Modern medicine is continually advancing treatment options for many chronic health conditions